Edwards Lifesciences Corporation Foreign Currency Transaction Gain (Loss), before Tax
Edwards Lifesciences Corporation (EW) reported Foreign Currency Transaction Gain (Loss), before Tax of $700.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-02-25
- Edwards Lifesciences Corporation foreign currency transaction gain (loss), before tax for the quarter ending 2015-03-31 was -$1.50M, a 125.42% decline year-over-year.
- Edwards Lifesciences Corporation foreign currency transaction gain (loss), before tax for the quarter ending 2014-03-31 was $5.90M.
- Edwards Lifesciences Corporation foreign currency transaction gain (loss), before tax for fiscal 2025 was $700.00K, a 90.14% decline from fiscal 2024.
- Edwards Lifesciences Corporation foreign currency transaction gain (loss), before tax for fiscal 2024 was $7.10M, a 29.00% decline from fiscal 2023.
- Edwards Lifesciences Corporation foreign currency transaction gain (loss), before tax for fiscal 2023 was $10.00M, a 900.00% increase from fiscal 2022.
- Edwards Lifesciences Corporation foreign currency transaction gain (loss), before tax for fiscal 2022 was $1.00M, a 80.00% decline from fiscal 2021.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | $700.00K 10-K · filed 2026-02-25 | ||
| 2024-12-31 | $7.10M 10-K · filed 2026-02-25 | ||
| 2023-12-31 | $10.00M 10-K · filed 2026-02-25 | $10.50M 10-K · filed 2024-02-12 | |
| 2022-12-31 | $1.00M 10-K · filed 2025-02-28 | -$1.20M 10-K · filed 2023-02-13 | |
| 2021-12-31 | $5.00M 10-K · filed 2024-02-12 | ||
| 2020-12-31 | $12.30M 10-K · filed 2023-02-13 | ||
| 2019-12-31 | $5.90M 10-K · filed 2022-02-14 | ||
| 2018-12-31 | $6.70M 10-K · filed 2021-02-12 | ||
| 2017-12-31 | -$5.40M 10-K · filed 2020-02-14 | ||
| 2016-12-31 | -$500.00K 10-K · filed 2019-02-15 | ||
| 2015-12-31 | -$4.80M 10-K · filed 2018-02-16 | ||
| 2015-03-31 | -$1.50M 10-Q · filed 2015-04-29 | ||
| 2014-12-31 | -$2.00M 10-K · filed 2017-02-17 | ||
| 2014-03-31 | $5.90M 10-Q · filed 2015-04-29 | ||
| 2013-12-31 | -$1.50M 10-K · filed 2016-02-19 | ||
| 2012-12-31 | -$1.20M 10-K · filed 2015-02-20 | ||
| 2011-12-31 | -$1.90M 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |